skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia

Journal Article · · Toxicological Sciences
 [1];  [1];  [1];  [2];  [2]; ORCiD logo [1]
  1. Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, USA
  2. Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, USA

Quantification of variation in levels of spontaneously occurring cancer driver mutations (CDMs) was developed to assess clonal expansion and predict future risk of neoplasm development. Specifically, an error-corrected next-generation sequencing method, CarcSeq, and a mouse CarcSeq panel (analogous to human and rat panels) were developed and used to quantify low-frequency mutations in a panel of amplicons enriched in hotspot CDMs. Mutations in a subset of panel amplicons, Braf, Egfr, Kras, Stk11, and Tp53, were related to incidence of lung neoplasms at 2 years. This was achieved by correlating median absolute deviation (MAD) from the overall median mutant fraction (MF) measured in the lung DNA of 16-week-old male and female, B6C3F1 and CD-1 mice (10 mice/sex/strain) with percentages of spontaneous alveolar/bronchioloalveolar adenomas and carcinomas reported in bioassay control groups. A total of 1586 mouse lung mutants with MFs > x 10-4 were recovered. The ratio of nonsynonymous to synonymous mutations was used to assess the proportion of recovered mutations conferring a positive selective advantage. The greatest ratio was observed in what is considered the most lung tumor-sensitive model examined, male B6C3F1 mice. Of the recurrent, nonsynonymous mouse mutations recovered, 55.5% have been reported in human tumors, with many located in or around the mouse equivalent of human cancer hotspot codons. MAD for the same subset of amplicons measured in normal human lung DNA samples showed a correlation of moderate strength and borderline significance with age (a cancer risk factor), as well as age-related cumulative lung cancer risk, suggesting MAD may inform species extrapolation.

Research Organization:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
DOE Contract Number:
SC0014664
OSTI ID:
1982722
Journal Information:
Toxicological Sciences, Vol. 184, Issue 1; ISSN 1096-6080
Publisher:
Oxford University Press
Country of Publication:
United States
Language:
English

References (33)

Quantification of cancer driver mutations in human breast and lung DNA using targeted, error‐corrected CarcSeq journal September 2020
The mutational landscape of normal human endometrial epithelium journal April 2020
Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas journal April 2016
Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium journal August 2018
Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment journal October 2001
Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan journal July 2019
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis journal June 2016
Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk journal October 2019
Age-related remodelling of oesophageal epithelia by mutated cancer drivers journal January 2019
High burden and pervasive positive selection of somatic mutations in normal human skin journal May 2015
CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia journal April 2021
The Tg rasH2 Mouse in Cancer Hazard Identification journal January 2002
Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas: Tissue-Specific Properties of Hotspot Cancer-Driver Mutations journal July 2017
Changing the field of carcinogenicity testing of human pharmaceuticals by emphasizing mode of action journal April 2017
Carcinogenicity Evaluation: Comparison of Tumor Data from Dual Control Groups in the CD–1 Mouse journal June 2007
A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies journal February 2020
Somatic mutant clones colonize the human esophagus with age journal October 2018
Universal Patterns of Selection in Cancer and Somatic Tissues journal November 2017
Incidence of Spontaneous Non-Neoplastic Lesions in Transgenic CBYB6F1-Tg(HRAS)2Jic Mice journal February 2013
A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroid: KRAS MUTANT FRACTION IN PAPILLARY THYROID TUMORS journal August 2012
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults journal August 2016
Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision Oncology journal February 2019
Gender differences in the incidence of background and chemically induced primary pulmonary neoplasms in B6C3F1 mice: A retrospective analysis of the National Toxicology Program (NTP) carcinogenicity bioassays journal November 2013
Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop journal December 2017
Selective Pressures on Human Cancer Genes along the Evolution of Mammals journal November 2018
ACB-PCR Quantification of K- RAS Codon 12 GAT and GTT Mutant Fraction in Colon Tumor and Non-Tumor Tissue journal April 2010
Age and Cancer Risk journal March 2014
Relevance of mouse lung tumors to human risk assessment journal May 2020
Multiclonal tumor origin: Evidence and implications journal July 2018
Next‐Generation Genotoxicology: Using Modern Sequencing Technologies to Assess Somatic Mutagenesis and Cancer Risk journal November 2019
Differential Transcriptomic Analysis of Spontaneous Lung Tumors in B6C3F1 Mice: Comparison to Human Non–Small Cell Lung Cancer journal June 2012
Low-frequency KRAS mutations are prevalent in lung adenocarcinomas journal March 2015
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers journal October 2018